Compendia are important reference tools for physicians, practice managers, and payers regarding accepted clinical uses of products. Creating a compendia strategy can be a key step to ensuring coverage of important off-label indications for products.
Xcenda's new Compendia White Paper provides an overview of the review processes of various compendia, as well as a landscape assessment of the key players and their processes. The Compendia White Paper will help manufacturers understand the following:
Cost: $5,000
Delivered within 2 to 3 weeks
Xcenda can also provide compendia strategy and analysis, compendia submissions, and compendia surveillance for products and indications of interest. We are also experienced in literature analyses to identify potential strengths and weaknesses in clinical evidence required for submission to compendia.
To discuss your objectives related to compendia, or to request more information from an Xcenda reimbursement strategy consultant, please complete the form below. Or, contact us directly via email or by phone: 908.883.1609.